Clinical Trials Sponsored by Tianjin Second People's Hospital

Total 997 results

Tianjin Second People's Hospital

Not yet recruiting

Endoscopic and Microbiological Assessment of the Effect of Carvedilol Combined With Berberine on GOV in Cirrhosis (CABER)

Gastroesophageal Varices | Cirrhosis Due to Hepatitis B | Cirrhosis Due to Hepatitis C

China
HUANG XIANJIAN

Unknown

Vitamin K1 in the Treatment of Spontaneous Intracerebral Hemorrhage

Intracerebral Haemorrhage in Cerebellum

China
Tianjin Medical University Second Hospital

Recruiting

Oncolytic Adenovirus(H101) Combined With PD-1 Inhibitors in Patients With Advanced Malignant Pleural Mesothelioma

Malignant Pleural Mesothelioma, Advanced

China
Tianjin Medical University Second Hospital

Recruiting

Pemigatinib for FGF/FGFR Alterations Advanced Pan Solid Tumors

Solid Tumor | FGF Receptor Gene Mutation | FGF Amplification | FGF Receptor Gene Family Rearrangement | FGF Receptor Gene Translocation

China
Tianjin Medical University Second Hospital

Recruiting

Tislelizumab Plus Lenvatinib in Stage III-IV RCC (TILUR)

Advanced Kidney Cancer

China
Tianjin Medical University Second Hospital

Recruiting

Tilelizumab Combined With Nab-Paclitaxel for High-Risk Non-Muscle-Invasive Urothelial Bladder Carcinoma Which is Not Completely Resectable: a Multi-center Study

High-Risk Non-Muscle Invasive Bladder Urothelial Carcinoma

China
Tianjin Medical University Second Hospital

Recruiting

Perioperative Tislelizumab Combined With Nab-Paclitaxel for Muscle-invasive Urothelial Bladder Cancer: A Multicenter Study

Muscle Invasive Bladder Cancer Urothelial Carcinoma

China
Tianjin Medical University Second Hospital

Not yet recruiting

A Study of Sintilimab in Combination With Axitinib in Advanced Renal Cell Cancer (SAARCC)

Renal Cell Carcinoma | Clear Cell Renal Cell Carcinoma

China
Tianjin Medical University Second Hospital

Recruiting

Tilelizumab Combined With Nab-Paclitaxel for High-Risk Non-Muscle-Invasive Urothelial Bladder Carcinoma Which is Not Completely Resectable

Non-Muscle Invasive Bladder Urothelial Carcinoma | High-Risk

China
Tianjin Medical University Second Hospital

Not yet recruiting

Sintilimab After Stereotactic Ablation Brachytherapy for Refractory Oligometastatic Non-Small Cell Lung Cancer

Lung Neoplasms | Oligometastasis
Tianjin Medical University Second Hospital

Completed

Study on the Influencing Factors of Electroencephalogram Parameters Under Anesthesia

EEC

China
Tianjin Medical University Second Hospital

Unknown

Personalized Therapy of Molecular Tumor Board Participation With the Guidance of Next Generation Sequencing

Solid Tumor, Adult

China
Tianjin Medical University Second Hospital

Recruiting

Disitamab Vedotin Combined With Tislelizumab for Her2 Overexpressing High-Risk Non-Muscle-Invasive Urothelial Bladder Carcinoma Which is Not Completely Resectable

Her2 Overexpressing High-Risk Non-Muscle Invasive Bladder Urothelial Carcinoma

China
Tianjin Medical University Second Hospital

Not yet recruiting

Pembrolizumab and Axitinib as Neoadjuvant Therapy for Locally Advanced Non-metastatic Clear Cell Renal Cell Carcinoma (PANDORA)

Renal Cell Carcinoma | Clear Cell Renal Cell Carcinoma

China
Tianjin Medical University Second Hospital

Recruiting

Selective Treatment According to Molecular Subtype of Prostate Cancer (STAMP)

Castration-resistant Prostate Cancer | Prostate Cancer Metastatic

China
Tianjin Medical University Second Hospital

Active, not recruiting

Perioperative Tislelizumab Combined With Nab-Paclitaxel for Muscle-invasive Urothelial Bladder Carcinoma

Urothelial Carcinoma | Muscle Invasive Bladder Cancer

China
Tianjin Medical University Second Hospital

Unknown

A Study of Fluzoparib Combined With Apatinib as Second-Line Treatment of Patients With Extensive Stage Small Cell Lung Cancer（FA-ES-SCLC）

Small Cell Lung Cancer Extensive Stage

China
Tianjin Medical University Second Hospital

Unknown

Advanced Refractory Solid Tumors With TP53 Mutations Register Study

Solid Tumor, Adult

China
Tianjin Medical University Second Hospital

Recruiting

MyCustom:Prospective Master Protocol Trial on Precision Medicine Treatment for Refractory Solid Tumors

Refractory Solid Tumors | Next Generation Sequencing

China
Tianjin Medical University Second Hospital

Recruiting

Nimotuzumab for EGFR-amplified Advanced Pan Solid Tumors

Solid Tumor | EGFR Amplification

China
Tianjin Medical University Second Hospital

Recruiting

Cadonilimab Plus Nab-Paclitaxel for Recurrent or Metastatic Muscle Invasive Bladder Cancer

Bladder Cancer

China
Tianjin Medical University Second Hospital

Recruiting

DOTr/DOTa Algorithm Guidance for Refractory Solid Tumors

Solid Tumor | Individuation

China
Tianjin Medical University Second Hospital

Recruiting

Efficacy and Safety of Tislelizumab in Combination With Disitamab-vedotin as Neoadjuvant Therapy for HER2-positive High-risk Upper Tract Urothelial Carcinoma (UTUC)

Neoadjuvant Immunotherapy

China
Tianjin Medical University Second Hospital

Recruiting

Pembrolizumab Plus Lenvatinib in Stage III-IV RCC

Advanced Kidney Cancer

China
Tianjin Medical University Second Hospital

Recruiting

A Study of Probiotics Administration in the Immunotherapy of Urothelial Bladder Carcinoma

Bladder Urothelial Carcinoma

China
Tianjin Medical University Second Hospital

Not yet recruiting

Anlotinib Combined With Platinum/Gemcitabine for First Line Treatment of Advanced Urothelial Carcinoma

Urogenital Neoplasms | Urothelial Carcinoma | Antineoplastic Agents | Gemcitabine | Cisplatin | Anlotinib | Carboplatin

China
Tianjin Medical University Second Hospital

Unknown

Personalized Mini-PDX for Metastatic CRPC

Prostate Cancer

China
Tianjin Medical University Second Hospital

Unknown

Predictive Nomogram of CRPC (CRPC-PN)

Metastatic Cancer | Castration-resistant Prostate Cancer

China
Shenzhen Second People's Hospital

Not yet recruiting

Rapid Detection Method for Microorganisms in the Lower Genital Tract

Infertility, Female
Shenzhen Second People's Hospital

Not yet recruiting

Analgesic Effect of Esketamine in DCSB in Adultscontrolled Study

Burns | Analgesia
Shenzhen Second People's Hospital

Recruiting

Oxford Classification and Clinical Remission After Initial Treatments in Patients With IgA Nephropathy

IgA Nephropathy

China
Shenzhen Second People's Hospital

Recruiting

Construction and Effect Evaluation of Integrated Care Model for Pulmonary Infection in Stroke Patients With Tracheotomy

Stroke | Pulmonary Infection

China
Shenzhen Second People's Hospital

Recruiting

Dose Reduced Dasatinib (70 mg Daily) as First-line Treatment for Newly Diagnosed CML-CP

Chronic Myeloid Leukemia | Dasatinib | BCR-ABL

China
Shenzhen Second People's Hospital

Completed

Comparing the Responsiveness of Barthel Index and Longshi Scale in Assessing the ADL of Stroke Survivors

Stroke | Disability Physical

China
Shenzhen Second People's Hospital

Completed

Eltrombopag vs. rhTPO to Increase Platelet Level After HSCT

Thrombocytopenia | Hematopoietic Stem Cell Transplantation | Eltrombopag

China
Shenzhen Second People's Hospital

Completed

Development and Application of Intelligent Assessment System of Longshi Scale

Stroke | Disability Physical

China
Shenzhen Second People's Hospital

Completed

UPDRS-III Comparisons of DBS for PD Between Patients Receiving MAC and AAA Anesthesia

Parkinson Disease | Anesthesia

China
Shenzhen Second People's Hospital

Unknown

Leflunomide Plus Low Dose Corticosteroid in Immunoglobulin A (IgA) Nephropathy With Renal Insufficiency

Renal Insufficiency, Chronic | Glomerulonephritis, IGA

China
Shenzhen Second People's Hospital

Unknown

Anti-BCMA or/and Anti-CD19 CART Cells Treatment of Relapsed Multiple Myeloma

Multiple Myeloma in Relapse

China
Shenzhen Second People's Hospital

Unknown

The Clinical Study of Bundle Measures to Improve the Success Rate of Patients With Difficult Ventilator Weaning

Weaning Failure

China
Shenzhen Second People's Hospital

Not yet recruiting

HFNO Improves Blood Oxygen Saturation During Asphyxia During Pulmonary Surgery With Double-lumen Endotracheal Intubation

Pneumothorax | Lung Neoplasms
Shenzhen Second People's Hospital

Not yet recruiting

The Value of Full-targeted Pathogen Capture Metagenomics Next Generation Sequencing in Etiological Diagnosis of Sepsis

Sepsis, Severe
Shenzhen Second People's Hospital

Recruiting

Efficacy of Double Contrast-enhanced Ultrasound of Pelvic in Preoperative Evaluation of Deep Endometriosis

Deep Endometriosis

China
Shenzhen Second People's Hospital

Recruiting

Modified Laparoendoscopic Rendezvous for Secondary Choledocholithiasis: a Nonrandomized Controlled Clinical Study

Choledocholithiasis

China
Shenzhen Second People's Hospital

Not yet recruiting

Development and Validation of the Prediction Model for Cognitive Impairment

Stroke, Acute
Shenzhen Second People's Hospital

Not yet recruiting

Establishment and Validation of a Predictive Model for Hemorrhage

Stroke, Acute

China
Shenzhen Second People's Hospital

Not yet recruiting

the Safety and Efficacy of Antiplatelet Therapy in Patients of CAA

Cerebral Amyloid Angiopathy
Shenzhen Second People's Hospital

Not yet recruiting

Maternal Exercise and Antenatal Anxiety

Anxiety
Shenzhen Second People's Hospital

Recruiting

The Effects of Different Anesthesia Methods on Perioperative Neurocognitive Disorders in the Elderly

PND

China
Shenzhen Second People's Hospital

Recruiting

Azacytidine + HAG Regimen vs. Azacytidine for Elderly Patients With Newly Diagnosed Myeloid Malignancy

Acute Myeloid Leukaemia; Myelodysplastic Syndromes;Chronic Myelomonocytic Leukemia

China

Clinical Trials Sponsored by Tianjin Second People's Hospital

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Equatorial Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations